Hilbe, W. Et Al. 2013. CECOG experts' recommendations on the use of denosumab in the prevention of skeletal-related events in bone metastases of lung cancer. Memo - Magazine of European Medical Oncology , vol.6, no.2 , 75-82.

Hilbe, W., Abacioglu, U., Aebersold, D. M., Bachouchi, M., Brodowicz, T., Gaafar, R., ... Holzer, G.(2013). CECOG experts' recommendations on the use of denosumab in the prevention of skeletal-related events in bone metastases of lung cancer. Memo - Magazine of European Medical Oncology , vol.6, no.2, 75-82.

Hilbe, Wolfgang Et Al. "CECOG experts' recommendations on the use of denosumab in the prevention of skeletal-related events in bone metastases of lung cancer," Memo - Magazine of European Medical Oncology , vol.6, no.2, 75-82, 2013

Hilbe, Wolfgang Et Al. "CECOG experts' recommendations on the use of denosumab in the prevention of skeletal-related events in bone metastases of lung cancer." Memo - Magazine of European Medical Oncology , vol.6, no.2, pp.75-82, 2013

Hilbe, W. Et Al. (2013) . "CECOG experts' recommendations on the use of denosumab in the prevention of skeletal-related events in bone metastases of lung cancer." Memo - Magazine of European Medical Oncology , vol.6, no.2, pp.75-82.

@article{article, author={Wolfgang Hilbe Et Al. }, title={CECOG experts' recommendations on the use of denosumab in the prevention of skeletal-related events in bone metastases of lung cancer}, journal={Memo - Magazine of European Medical Oncology}, year=2013, pages={75-82} }